Search results
Tribeca-Bound Sci-Fi Horror ‘She Loved Blossoms More’ Unveils Teaser (EXCLUSIVE)
Variety· 4 hours ago“Norway” director Yannis Veslemes‘ “She Loved Blossoms More,” which will world premiere at the...
..., fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at...
Valley City Times Record· 5 days agoThe preliminary result of the trial was accepted as a late-breaking abstract and selected for oral...
Are NFTs Dead?
Rolling Stone· 3 days agoTo most people, non-fungible tokens (NFTs) are those weird, often abstract and (they think) ugly pieces of digital art that sell for thousands of dollars...
...PharmaNest to Present Seven Digital Pathology and AI Communications and Abstracts at the...
Digital Journal· 3 days agoThe abstracts highlight the utility and performance of its FibroNest Ph-FCS digital pathology...
For This Indigenous Beadworker, Every Stitch ‘Is an Act of Resistance’
New York Times· 9 hours agoTeri Greeves builds on a legacy of artistry, rarely recognized by mainstream institutions, that...
How Do You Create an Icon? Take a Look at Elsa Peretti and Tiffany
Elle Decor via Yahoo News· 2 days agoThe woman responsible for the creation, Elsa Peretti, found the vase at a flea market and had it...
3 Unique Ways To Celebrate Pride Month While Embracing The Arts In New York
Forbes· 13 hours agoEmbracing the queer art and LBGTQ artists living in our lifetime is especially critical for...
Käthe Kollwitz’s Raw Scrapes
The New Yorker· 8 hours agoThe Museum of Modern Art has convened a major Kollwitz retrospective, the largest such show in the U.S. in three decades and the first in New York City....
Auriea Harvey’s Digital Worlds Are Love Stories, Without Neat Ends
New York Times· 9 hours agoThe first survey of the influential Net artist turned game developer traces the evolution of digital...
Jazz Pharmaceuticals stock maintains Outperform rating By Investing.com
Investing.com· 7 hours agoOn Thursday, RBC (TSX:RY) Capital Markets sustained its Outperform rating and $176.00 price target...